Efficacy of pomalidomide plus low-dose dexamethasone in multiple myeloma patients despite previous use of lenalidomide.
J. Mikhael
Research Funding - Celgene; Genzyme; Novartis; Sanofi
V. Rajkumar
No relevant relationships to disclose
V. Roy
No relevant relationships to disclose
S. R. Hayman
No relevant relationships to disclose
R. Fonseca
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Genzyme; Lilly; Medtronic; Otsuka
Research Funding - Cylene; Onyx
K. Detweiler Short
No relevant relationships to disclose
B. LaPlant
No relevant relationships to disclose
K. M. Laumann
No relevant relationships to disclose
A. Dispenzieri
Honoraria - Binding Site
Research Funding - Celgene
M. Lacy
Research Funding - Celgene